Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Your donations help support people living with type 1 diabetes today and fund the best treatment and cure research, no matter where in the world it takes place.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
Join our Virtual Triathlon Challenge and swim, cycle and run while raising money to fund Breakthrough T1D’s life-changing type 1 research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > About Breakthrough T1D UK & our impact > Our research > Research projects > Can hybrid closed loop technology affect eye problems in type 1 diabetes?
People with type 1 diabetes (T1D) can sometimes develop worsening eye disease, called diabetic retinopathy, after a new treatment causes a sudden improvement in their blood glucose levels. We’ve teamed up with The Novo Nordisk UK Research Foundation to co-fund Dr Matthew Anson, a doctor at Aintree University Hospital in Liverpool, to study how hybrid closed loop technology might affect the worsening of diabetic retinopathy.
People with T1D are at greater risk of developing eye problems like diabetic retinopathy. In diabetic retinopathy, the blood vessels in the back of the eye become damaged due to persistently high blood glucose. This can lead to vision loss if left untreated. Learn more about T1D and eye problems.
Paradoxically, people with T1D can sometimes develop a worsening of diabetic retinopathy if their blood glucose levels improve rapidly, for example as the result of a new treatment.
Hybrid closed loop (HCL) technology takes readings from a continuous glucose monitor and uses an algorithm to tell an insulin pump how much insulin to deliver. This recent technological advancement can lead to a sudden improvement in blood glucose levels. This is important in helping to prevent long-term T1D complications like heart disease, but it may worsen diabetic retinopathy in some people.
In this project, Matthew will look at how diabetic retinopathy changes in people starting on HCL compared to those on insulin injections. He will also investigate the biological processes that are driving these changes so that treatments can be developed to intervene with them.
By taking images of the eye and measures of electrical activity, he will be able to tell how many people develop worsening diabetic retinopathy and who are most at risk. Matthew will also work with experts in artificial intelligence to create a software that predicts the worsening of diabetic eye disease.
This project will benefit people with T1D by helping healthcare professionals detect and diagnose diabetic retinopathy earlier, which could lead to more personalised treatment. It will also raise awareness among both patients and healthcare professionals about those at risk of developing diabetic eye disease, allowing earlier intervention and helping to prevent vision loss. The project may also lead to the development of new treatments for diabetic retinopathy and improve access to eye screenings, ensuring better care and outcomes for people with T1D.
We fund lots of research into managing, delaying and preventing complications associated with T1D. We also support research that aims to find new ways to prevent the development of diabetic eye disease, stop its progression to preserve visual function, and restore lost vision through our partnership with the Mary Tyler Moore Vision Initiative.
Dr Samet Sahin is developing a simple tool to allow healthcare professionals to quickly and easily check someone’s C-peptide levels, a measure of how much insulin they are releasing.
Dr Thomas George Hill is studying a type of pancreatic islet cell, called a delta cell, which he thinks could be targeted with a treatment to help prevent low blood glucose in type 1 diabetes.
Dr Richard Pulsford is developing a visual tool for people with type 1 diabetes that predicts the likelihood of their blood glucose going too low during exercise
Dr Mandeep Kaur Marwah is developing a new type of dressing to help diabetic wounds heal more quickly.